secwatch.observer — SEC 8-K summary
======================================

Issuer:     Totaligent, Inc. (TGNT)
CIK:        0000846377
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001477932-26-001611
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Totaligent extends GloMed joint venture LOI deadline to April 22, 2026
----------------------------------------------------------------------

- Extension Amendment moves target closing date from March 22 to April 22, 2026.
- Binding exclusivity period extended through April 22, 2026.
- Delay attributed to ongoing due diligence and negotiations for definitive agreements.
- All other terms of the original LOI remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/846377/000147793226001611/0001477932-26-001611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/846377/000147793226001611/totaligent_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-001611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer